Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FU633
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,121
Award facts
- Contract value 100% obligated
- $4,120.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,120.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count unit dose) on December 10, 2025, with completion scheduled for December 11, 2025. This non-competitive, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical support vehicle for the Defense Health Agency and military healthcare systems worldwide. The company serves as a critical pharmaceutical distributor supplying brand-name and generic medications, specialty drugs, and medical supplies across multiple therapeutic domains. RINVOQ (upadacitinib) is a prescription medication indicated for rheumatoid arthritis and other autoimmune conditions, reflecting the breadth of medical products AmerisourceBergen furnishes to support federal military and veteran healthcare operations through its established DLA prime vendor relationship.
Quick answers
Who was awarded contract SPE2DR26FU633?
SPE2DR26FU633 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FU633 worth?
The government has obligated $4,121 on SPE2DR26FU633.
Is contract SPE2DR26FU633 an order under another contract?
Yes. SPE2DR26FU633 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU633 competed?
The extent of competition for SPE2DR26FU633 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award